Literature DB >> 15901924

High-sensitivity cytotoxicity assays for nonadherent cells.

M Jules Mattes1.   

Abstract

High-sensitivity cytotoxicity assays refer to assays that can detect high levels of cell kill, to many powers of 10, and that can detect, ideally, a single remaining viable cell. Two such assays are described here, which have been used with Raji B-lymphoma cells, and are applicable to other nonadherent target cells. The first is a cell-counting assay, performed over a 3-wk period, which provides a simple, reliable, and sensitive assay of cytotoxicity. By determining the time required for 16-fold multiplication, the apparent fraction surviving can be calculated. This assay does not correct for treatment-induced delays in cell division and is dependent on maintaining the cells in exponential growth. The second assay measures colony-forming units using a limiting dilution method. Feeder cells are required to obtain a high cloning efficiency. Each dilution is plated in 48 wells of a 96-well plate, and positive wells are scored rapidly, by eye, after two wk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15901924     DOI: 10.1385/1-59259-869-2:029

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  2 in total

1.  Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutase.

Authors:  Charles O Brown; Kelley Salem; Brett A Wagner; Soumen Bera; Neeraj Singh; Ajit Tiwari; Amit Choudhury; Garry R Buettner; Apollina Goel
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

2.  Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma.

Authors:  Kelley Salem; Michael L McCormick; Erik Wendlandt; Fenghuang Zhan; Apollina Goel
Journal:  Redox Biol       Date:  2014-11-18       Impact factor: 11.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.